1. Galectin-3 mediates cardiac remodeling caused by impaired glucose and lipid metabolism through inhibiting two pathways of activating Akt
   Zhen Sun et al, 2021, American Journal of Physiology-Heart and Circulatory Physiology CrossRef
2. Protective effect of Galectin-3 inhibitor against cardiac remodelling in an isoprenaline-induced myocardial infarction in type 2 diabetes
   Manal Moustafa Mahmoud et al, 2024, Archives of Physiology and Biochemistry CrossRef
3. The utility of growth differentiation factor-15, galectin-3, and sST2 as biomarkers for the diagnosis of heart failure with preserved ejection fraction and compared to heart failure with reduced ejection fraction: a systematic review
   Simon W. Rabkin et al, 2021, Heart Failure Reviews CrossRef
4. Unraveling the role of galectin-3 in cardiac pathology and physiology
   Ignacio M. Seropian et al, 2023, Frontiers in Physiology CrossRef
5. Galectin-3 interferes with tissue repair and promotes cardiac dysfunction and comorbidities in a genetic heart failure model
   Fani Vlachou et al, 2022, Cellular and Molecular Life Sciences CrossRef
6. Circulating galectin-3 on admission and prognosis in acute heart failure patients: a meta-analysis
   Hongsen Chen et al, 2020, Heart Failure Reviews CrossRef